LDR | |
01289nam a2200265Ia 4500 |
001 |
|
009497614 |
003 |
|
MiAaHDL |
005 |
|
20150901000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
861212s1986 cau s00010 eng d |
035 |
⊔ |
⊔ |
‡asdr-ucbk.b117318929
|
040 |
⊔ |
⊔ |
‡aCDL
‡cCDL
‡dCU-IG
|
043 |
⊔ |
⊔ |
‡an-us-ca
|
035 |
⊔ |
⊔ |
‡a(OCoLC)14964155
|
110 |
1 |
0 |
‡aCalifornia.
‡bLegislature.
‡bSenate.
‡bCommittee on Health and Human Services.
‡bSubcommittee on Mental Health, Developmental Disabilities and Genetic Diseases.
|
245 |
1 |
0 |
‡aIn re PCP use :
‡bthe medical and mental health implications : hearing before the Senate Subcommittee on Mental Health, Developmental Disabilities and Genetic Diseases, Isaac Newton Center Auditorium, 70 West Hedding Street, San Jose, California, Monday, July 14, 1986, 9:30 a.m.
|
260 |
0 |
⊔ |
‡aSacramento, CA :
‡bJoint Publications,
‡c[1986]
|
300 |
⊔ |
⊔ |
‡av leaves, 187 p. ;
‡c28 cm.
|
500 |
⊔ |
⊔ |
‡aCover title: Hearing on PCP use.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aPhencyclidine abuse
‡zCalifornia.
|
650 |
⊔ |
0 |
‡aPhencyclidine.
|
740 |
0 |
1 |
‡aHearing on PCP use.
|
740 |
0 |
1 |
‡aPCP use.
|
CID |
⊔ |
⊔ |
‡a009497614
|
DAT |
0 |
⊔ |
‡a19150731000000.0
‡b20150901000000.0
|
DAT |
1 |
⊔ |
‡a20150901153633.0
‡b2023-10-15T17:43:07Z
|
CAT |
⊔ |
⊔ |
‡aSDR-UCBK
‡dIII - MILLENIUM
‡lprepare.pl-004-003
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-ucbk.b117318929
‡auc1
‡bSDR
‡cUCBK
‡puc1.b000647793
‡sUC
‡1.b117318929
|
974 |
⊔ |
⊔ |
‡bUC
‡cUCBK
‡d20231015
‡sgoogle
‡uuc1.b000647793
‡y1986
‡ric
‡qbib
‡tUS bib date1 >= 1929
|